Cybin (HELP) Non Operating Income (2020 - 2026)
Cybin (HELP) posted quarterly Non Operating Income of $864000.0 for Q1 2026, down 53.94% year-on-year from $1.9 million in Q1 2025, and up 159.26% on a QoQ basis from -$1.5 million in Q4 2025.
Cybin (HELP) Non Operating Income (2020 - 2026) Analysis & Trends
Cybin (HELP) has reported Non Operating Income for 7 consecutive years, with $864000.0 the latest figure, recorded in Q1 2026.
- Quarterly Non Operating Income fell 53.94% year-over-year to $864000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 130.91% YoY) and the FY2026 annual result came in at -$5.4 million, down 125.15% from the prior year.
- Non Operating Income grew to $864000.0 in Q1 2026 per HELP's latest filing, from -$1.5 million in the prior quarter.
- Over the last five years, Non Operating Income for HELP reached as high as $14.8 million in Q4 2024 and fell as low as -$4.8 million in Q3 2025.
- A 5-year average of $884752.1 and a median of $5493.0 in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2024 — Non Operating Income jumped 611579.01% — and 2025, when it plunged 720.57%.
- Year by year, Non Operating Income stood at $995285.7 in 2022, then plunged by 100.24% to -$2428.4 in 2023, then soared by 611579.01% to $14.8 million in 2024, then slumped by 109.82% to -$1.5 million in 2025, then soared by 159.26% to $864000.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $864000.0, -$1.5 million, and -$4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | 864,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 864,000.00 |
| Dec 31, 2025 | -1.46 Mn |
| Sep 30, 2025 | -4.83 Mn |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | 14.85 Mn |
| Sep 30, 2024 | 778,000.00 |
| Jun 30, 2024 | 5,493.00 |
| Dec 31, 2023 | -2,428.37 |
| Sep 30, 2023 | 1,506.78 |
| Jun 30, 2023 | -1.35 Mn |
| Feb 28, 2023 | 1.52 Mn |
| Dec 31, 2022 | 995,285.67 |
| Sep 30, 2022 | 2,354.00 |
| Mar 31, 2022 | -1,759.00 |
| Dec 31, 2021 | -755.00 |
| Sep 30, 2021 | -397,999.06 |
| Jun 30, 2021 | -632.92 |
| Mar 31, 2021 | -1,414.00 |
| Dec 31, 2020 | -30,682.19 |